GERN - Intrinsic Value and Financial Analysis - Geron Corporation

Geron Corporation GERN

Healthcare - Biotechnology - NASDAQ - US

Watchlist

$ 3.66

-1.35 %

$ 2.21 B

Market Cap

-11.44

P/E

BALANCE SHEET

394 M ASSETS

Growth Rates

1Year 106.78%

3Years 13.33%

5Years 16.29%

7Years 17.13%

10Years 19.32%

146 M LIABILITIES

Growth Rates

1Year 32.15%

3Years 34.71%

5Years 80.86%

7Years 51.80%

10Years 34.42%

248 M EQUITY

Growth Rates

1Year 209.94%

3Years 5.53%

5Years 6.89%

7Years 10.61%

10Years 15.29%

BALANCE SHEET DECOMPOSITION

Balance Sheet Decomposition Geron Corporation

394 M ASSETS
146 M LIABILITIES

Current Assets	341 M
Cash & Short-Term Investments	334 M
Receivables	1.66 M
Other Current Assets	5.99 M
Non-Current Assets	52.7 M
Long-Term Investments	43.3 M
PP&E	4.73 M
Other Non-Current Assets	4.7 M

Current Liabilities	108 M
Accounts Payable	6.16 M
Short-Term Debt	47.8 M
Other Current Liabilities	54.1 M
Non-Current Liabilities	38.1 M
Long-Term Debt	38.1 M
Other Non-Current Liabilities	0

Balance Sheet

Millions

	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015	Dec-2014	Dec-2013	Dec-2012	Dec-2011	Dec-2010	Dec-2009	Dec-2008	Dec-2007	Dec-2006	Dec-2005	Dec-2004	Dec-2003	Dec-2002	Dec-2001	Dec-2000	Dec-1999	Dec-1998	Dec-1997	Dec-1996
ASSETS
Cash & Cash Equivalents	71.1	57.2	34.9	10.3	13.9	10.8	16.6	13.1	21.5	43.1	13.0	22.9	16.1	46.8	35.4	109.3	146.0	135.9	96.6	9.8	12.8	4.6	18.8	30.0	7.8	16.4	4.1	12.4
Short Term Investments	263.7	115.9	148.9	186.3	125.7	152.7	78.4	102.0	92.5	108.6	52.2	73.5	105.2	140.6	77.0	53.5	60.0	77.4	93.8	110.1	96.4	42.4	50.2	3.0	0	0	0	0
Receivables	1.7	3.1	1.8	0.7	0.8	1.2	0.4	0.5	1.2	1.0	0.6	0.8	1.4	1.8	1.3	0.9	0.8	1.3	2.3	1.7	1.2	1.1	1.5	1.2	0.7	0.5	0.9	0
Inventory	0	(3.1)	(1.4)	(0.7)	(0.8)	(1.2)	(0.4)	(0.5)	(1.2)	(1.0)	0	(0.8)	0	(1.8)	(1.3)	0	0	0	0	0	0	0	0.5	0	0	0	0	0
Other Current Assets	6.0	4.4	1.7	2.9	1.5	1.6	0.8	0.8	0.9	1.0	1.3	2.1	2.9	5.9	4.1	3.7	6.6	2.0	2.3	3.1	1.3	2.6	0.7	0.4	31.9	8.9	18.5	12.6
Total Current Assets	341.3	180.2	187.2	199.9	141.6	166.1	96.0	116.1	115.9	153.4	67.1	98.4	125.6	195.0	117.8	168.2	213.4	217.2	195.6	124.8	111.8	50.8	71.7	34.6	40.4	25.8	23.5	25.0
PP&E	4.7	0.8	5.4	0.7	0.4	59 K	0.1	0.2	0.2	0.2	92 K	1.0	1.2	3.1	3.9	4.4	4.1	2.5	2.8	2.1	1.7	2.4	3.6	3.7	3.8	2.3	2.4	3.0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.4	1.1	3.8	6.7	9.5	12.4	15.3	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	43.3	0	28.7	63.4	19.7	18.6	14.2	14.0	32.7	18.9	0	0	32.1	33.9	54.7	1.0	55 K	0.2	0.3	0.5	0.4	0	0	0	0	0	0	0
Other Long Term Assets	4.7	9.5	4.8	6.8	3.9	0.6	0	0	0	0	0.2	0.4	1.0	1.6	4.0	2.6	1.4	1.2	2.5	3.9	0.8	0.8	11.4	63.3	4.2	16.4	0.2	0.8
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	394.1	190.6	226.0	270.7	165.5	185.3	110.3	130.2	148.8	172.5	67.3	99.8	160.0	233.6	180.4	176.2	218.9	220.8	201.2	131.9	118.1	60.7	96.2	114.0	63.7	44.5	26.1	28.8
LIABILITIES
Accounts Payable	6.2	10.2	6.7	6.9	1.2	1.0	0.5	0.2	0.2	1.0	1.4	3.4	3.0	3.5	2.2	2.4	2.9	2.0	1.9	2.5	1.3	1.6	1.3	1.5	1.3	1.2	0.7	0.8
Short Term Debt	47.8	21.9	1.8	1.8	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	55 K	2.6	5.0	5.5	0.8	0.9	1.2	0.9	1.0	1.2
Other Current Liabilities	54.1	44.6	37.0	22.3	26.3	6.6	6.0	7.6	6.5	5.8	6.2	10.7	10.5	37.0	4.6	5.3	9.6	43.7	7.4	2.8	3.3	1.7	7.4	5.7	5.4	1.5	2.0	1.6
Total Current Liabilities	108.1	76.7	45.5	30.9	28.2	7.6	6.5	7.9	6.6	41.8	7.6	14.1	13.4	40.8	7.5	7.7	12.7	46.8	9.3	8.5	9.8	9.4	10.3	8.1	7.9	3.6	3.7	3.6
Long Term Debt	38.1	33.9	54.1	28.8	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	1.2	20.5	16.6	32.4	17.1	8.1	1.3	1.6
Deferred Tax Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(0.7)	(0.8)	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0.8	1.0	7.8	9.6	12.5	0	0	0
Total Liabilities	146.1	110.6	99.6	59.8	30.4	7.6	6.5	7.9	6.6	41.8	7.6	14.1	13.4	40.8	7.8	7.8	13.2	46.9	10.5	9.8	11.8	30.9	34.7	50.1	37.5	11.7	5.0	5.2
EQUITY
Common Stock	0.5	0.4	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	92 K	81 K	76 K	70 K	65 K	52 K	39 K	25 K	24 K	22 K	0	0	0	0
Retained Earnings	(1 597.8)	(1 413.6)	(1 271.7)	(1 155.6)	(1 080.0)	(1 011.5)	(985.8)	(957.9)	(928.4)	(928.4)	(892.8)	(854.4)	(785.5)	(688.6)	(577.3)	(506.9)	(444.9)	(399.1)	(369.6)	(336.1)	(255.7)	(225.8)	(191.9)	(149.8)	(104.0)	(57.5)	(46.1)	(36.5)
Other Accumulative Comprehensive Income/Loss	0.2	(0.2)	(0.2)	78 K	0.1	(0.2)	(0.2)	53 K	(0.2)	84 K	14 K	40 K	91 K	96 K	(0.4)	40 K	33 K	(0.2)	(0.9)	(0.9)	(0.7)	(0.6)	(0.2)	(0.3)	(1.0)	(4.8)	(3.7)	(2.5)
Total Equity	247.9	80.0	126.4	210.9	135.2	177.7	103.8	122.4	142.1	130.7	59.8	85.7	146.6	192.7	172.6	168.5	205.7	173.9	190.7	122.1	106.3	29.7	61.5	63.9	26.2	32.8	21.1	23.6
Total Liabilities and Equity	394.1	190.6	226.0	270.7	165.5	185.3	110.3	130.2	148.8	172.5	67.3	99.8	160.0	233.6	180.4	176.2	218.9	220.8	201.2	131.9	118.1	60.7	96.2	114.0	63.7	44.5	26.1	28.8
SHARES OUTSTANDING
Common Shares Outstanding	570.6	380.8	327.6	271.5	190.2	176.5	159.2	159.0	158.0	153.5	127.9	126.9	124.5	97.6	88.1	78.2	74.2	66.1	57.9	44.9	31.0	24.7	22.1	20.9	15.5	11.4	10.6	5.2

Balance Sheet

Premium Plan

Unlimited Plan